Therapeutic Drug Monitoring and Dose Adjustment of Posaconazole in Adult Patients with Acute Myeloid Leukemia: A Single-Center Experience
Class of 2014 Abstract === Specific Aims: Evaluate serum posaconazole concentrations following dose adjustment in response to subtherapeutic serum concentrations. Determine optimal dose adjustment schema and identify toxicity with doses above 600 mg daily (e.g.: 200 mg per os three times daily)....
| Main Authors: | , |
|---|---|
| Language: | en_US |
| Published: |
The University of Arizona.
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10150/614191 http://arizona.openrepository.com/arizona/handle/10150/614191 |